Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 3, 2006
Novel candidate genes in unstable areas of human atherosclerotic plaquesMarianna Papaspyridonos, Alberto Smith, Kevin G Burnand, et al.
Frontiers in Public Health|December 17, 2020
COVID-19 Solutions Are Climate Solutions: Lessons From Reusable GownsNatalie Baker, Rebecca Bromley-Dulfano, Joshua Chan, et al.
Diagnostic Microbiology and Infectious Disease|August 25, 2016
Fatigue in patients with erythema migransGary P Wormser, Praveen Sudhindra, Eliana Lopez, et al.
Environmental Pollution (Barking, Essex : 1987)|October 22, 2022
Characterization and regulation of microplastic pollution for protecting planetary and human healthYoun Soo Jung, Vanitha Sampath, Mary Prunicki, et al.
Biochemical and Biophysical Research Communications|January 12, 2002
PPARgamma is not a critical mediator of primary monocyte differentiation or foam cell formationLisa Patel, Steven J Charlton, Ian C Marshall, et al.
Health Affairs (Project Hope)|January 22, 2025
Critical Steps To Address Climate, Health, And EquityWilliam H Frist, Sonia Y Angell, Kristie L Ebi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2025
Phenotypic pharmacology of novel Complex I inhibitors eliciting tissue repair concurrent to control of inflammationLisa Patel, Fatima Garcia-Raposo, Benjamin Moore, et al.
Lancet (London, England)|August 8, 2006
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trialJoseph Eron, Patrick Yeni, Joseph Gathe, et al.
Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.
Pageof 5